Induced Nausea and Vomiting Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth ...

The results of these three large trials established palonosetron as an active and well-tolerated new 5-HT3 antagonist. In the setting of moderately emetogenic chemotherapy, there is a suggestion ...